Detailed Notes on BI8622
OMEPRAZOLE: There have been no improvements while in the pharmacokinetic parameters of both cerivastatin or its main active metabolites, or of omeprazole in wholesome youthful males specified solitary 0.3 mg oral doses of cerivastatin by itself or over the fifth day of a five-day omeprazole twenty m